BioCentury
ARTICLE | Clinical News

Reolysin: Phase III ongoing

June 25, 2012 7:00 AM UTC

Oncolytics said an independent DMC recommended continuation of the double-blind, placebo-controlled, international Phase III REO 018 trial evaluating IV Reolysin in combination with carboplatin and pa...